Prostate cancer: Surgery vs Radiation vs CyberKnife – Dr. David Samadi
An analysis of more than a dozen studies indicate that prostate cancer patients do better with surgery vs. radiation treatment; especially men with localized prostate cancer.
Patients treated with radiation are twice as likely to die from prostate cancer, one & a half times likely to die sooner than prostate cancer patients treated with surgery & exposure to radiation may end in secondary cancers such as bladder cancer and rectal cancer.
Dr. David Samadi explores the details.
When men are diagnosed with prostate cancer it can be extremely confusing at times picking the right treatment option as there’s a lot of information out there.
Dr David Samadi says that with any cancer, surgery should be the first line of treatment.
With prostate cancer surgery patients get accurate staging – i.e. how much cancer a patient has, has the cancer spread to surrounding tissues & the PSA levels which has always got to be zero.
Dr. David Samadi explains that there’s a lot of misleading advertisements indicating methods such as CyberKnife is robotic radio surgery which in fact is not but only a different form of radiation treatment.
He says that patients are led to believe that radiation is a viable first line of treatment & if the cancer comes back, it is extremely difficult to perform surgery after radiation.
Dr. Samadi also explain why it is extremely important to weigh in the experience of the surgeon as working with the right doctor would ensure a better and faster recovery.
Dr. David Samadi’s patients have a continence percentage of 95% – 97% & regular sexual functionality in about 80% of prostate cancer patients.
Some prostate cancer facts:
• There are over 221,000 men diagnosed each year
• Almost 21,000 die of prostate cancer
• If the cancer is spread outside the prostate gland, the chances of a man living longer than 5 years becomes less than 30%
• If the prostate is surgically removed, the survival rate becomes almost 100%
Dr. David Samadi also clarifies if there are genetic components where certain males are predisposed to having prostate cancer, why is it important not to just look at the PSA as a number but to follow a trend pattern.
It’s explained what factors have to be monitored closely & at what age / PSA levels a patient should start consider a biopsy or not.
Dr. Samadi explains why individualized care is of utmost importance & why patients should not be satisfied with ‘the one size fits all approach’ when it comes to Prostate cancer Surgery, Radiation & CyberKnife.
Dr. David Samadi is the Chairman of Urology & Robotics Surgery at Lenox Hill Hospital. He’s also a Fox News Medical-A-Team Contributor & Professor of Urology at Hofstra Northshore LIJ School of Medicine.
Dr. David Samadi Prostate Cancer Center is situated at 485 Madison Avenue, 21st Floor, New York, NY 10022 | Phone: +1-212-365-5000 (https://goo.gl/maps/mfansYfCMAn)
Connect with Dr. David Samadi: